S. Mahmoud

Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs Fund.

J. H. Brindley, C. Palmieri, R. Ramaswami, 2014, Future oncology.

Intravenous Versus Oral Dexamethasone Premedication in Preventing Paclitaxel Infusion Hypersensitivity Reactions in Gynecological Malignancies

J. Kwon, H. Gabra, R. Agarwal, 2013, International Journal of Gynecologic Cancer.

Development and economic trends in anticancer drugs licensed in the UK from 2015 to 2019.

J. Krell, Emily C. Mills, M. Lythgoe, 2020, Drug discovery today.

Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014

P. Savage, S. Mahmoud, 2015, British Journal of Cancer.

Cancer Drugs: An International Comparison of Postlicensing Price Inflation.

H. Kantarjian, P. Savage, S. Mahmoud, 2017, Journal of oncology practice.

SARS-CoV-2 Post Vaccinated Adverse Effects and Efficacy in the Egyptian Population

H. El‐Seedi, A. Alanazi, A. Alzarea, 2021, Vaccines.

Hypersensitivity reactions to etoposide phosphate

M. Seckl, P. Savage, S. Mahmoud, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis

M. Büchler, U. Keppler, A. Ulrich, 2017, Journal of surgical oncology.

Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab era.

S. Shousha, J. Krell, C. Palmieri, 2011, Clinical breast cancer.